Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03876665 · ClinicalTrials.gov registry record
The Experience of Living With Polycystic Ovary Syndrome in the Military
A clinical trial, sponsored by David Grant U.S. Air Force Medical Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT03876665: Completed study, sponsored by David Grant U.S. Air Force Medical Center.
NCT03876665 is a clinical trial that has completed, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03876665 has completed, sponsored by David Grant U.S. Air Force Medical Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the experience of living with polycystic ovary syndrome (PCOS) as an active duty Service Woman. As part of a budding research program, this proposed study will lay the groundwork for future intervention studies targeting the management of PCOS in a military population.
Primary Outcome
Information from focused groups (FG) discussions and individual interviews (II) will be transcribed, categorized and then organized into themes that describe the experiences of active duty service members
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2020-12-30 |
What the finished NCT03876665 record still lists
NCT03876665 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT03876665 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03876665 about?
NCT03876665 is a clinical study titled "The Experience of Living With Polycystic Ovary Syndrome in the Military". The purpose of this study is to understand the experience of living with polycystic ovary syndrome (PCOS) as an active duty Service Woman. As part of a budding research program, this proposed study will lay the groundwork for future intervention studies targeting the management of PCOS in a military...
What is the current status of trial NCT03876665?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2019-08-15. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT03876665?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT03876665?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI